Page 7 - CANNABIDIOL (CBD) Critical Review Report Geneva, 4-7 June 2018 World Health Organization

1. Substance identification

A. International Nonproprietary Name (INN)

Cannabidiol

B. Chemical Abstract Service (CAS) Registry Number

13956-29-1 [1]

C. Other Chemical Names

CBD;
2-[1R-3-methyl-6R-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-
benzenediol; [2]

D. Trade Names

Epidiolex® (in development)
Arvisol® (in development)

E. Street Names

No data available

F. Physical Appearance

A crystalline solid [2]

G. WHO Review History

th
The 38 ECDD recommended that pre-review documentation on cannabis-
related substances, including cannabidiol, be prepared and evaluated at a
subsequent committee meeting [3]. Cannabidiol has been pre-reviewed by
th
the 39 WHO Expert Committee on Drug Dependence (ECDD) in
November 2017. This review is an expansion and update of that initial pre-
review report.

2. Chemistry

A. Chemical Name

IUPAC Name: 2-[(6R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-
yl]-5-pentylbenzene-1,3-diol

6